SIRT1 Serum Concentrations in Lipodystrophic Syndromes
International Journal of Molecular Sciences · 27.04.2024 · 25 (9) · 4785
DOI: 10.3390/ijms25094785 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.04.2024. Verfasst von Luisa Salvatori und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Pathology, National Research Council (CNR), c/o Sapienza University of Rome, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Sirtuin 1, Lipodystrophy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research Grants, Sapienza University of Rome, Sapienza University of Rome, Ricerca di Ateneo 2022.
Abstract (Originalsprache)
Lipodystrophies (LDs) are rare, complex disorders of the adipose tissue characterized by selective fat loss, altered adipokine profile and metabolic impairment. Sirtuins (SIRTs) are class III NAD+-dependent histone deacetylases linked to fat metabolism. SIRT1 plays a critical role in metabolic health by deacetylating target proteins in tissue types including liver, muscle, and adipose. Circulating SIRT1 levels have been found to be reduced in obesity and increased in anorexia nervosa and patients experiencing weight loss. We evaluated circulating SIRT1 levels in relation to fat levels in 32 lipodystrophic patients affected by congenital or acquired LDs compared to non-LD subjects (24 with anorexia nervosa, 22 normal weight, and 24 with obesity). SIRT1 serum levels were higher in LDs than normal weight subjects (mean ± SEM 4.18 ± 0.48 vs. 2.59 ± 0.20 ng/mL) and subjects with obesity (1.7 ± 0.39 ng/mL), whereas they were close to those measured in anorexia nervosa (3.44 ± 0.46 ng/mL). Our findings show that within the LD group, there was no relationship between SIRT1 levels and the amount of body fat. The mechanisms responsible for secretion and regulation of SIRT1 in LD deserve further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Biology and Pathology, National Research Council (CNR), c/o Sapienza University of Rome, 00185 Rome, Italy.
- Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, 56124 Pisa, Italy.
- Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, Sapienza University of Rome, 00161 Rome, Italy.
- Chemistry and Endocrinology Laboratory, University Hospital of Pisa, 56124 Pisa, Italy.
ORCID-Profile: Silvia Magno, Giovanni Ceccarini, Rossella Tozzi, Ferruccio Santini, Stefania Mariani
Förderung
- Italian Ministry of University and Research Grants
- Sapienza University of Rome
- Sapienza University of Rome, Ricerca di Ateneo 2022
Zitieren
APA
Salvatori, L., Magno, S., Ceccarini, G., Tozzi, R., Contini, S., Pelosini, C., Santini, F., Gnessi, L., & Mariani, S. (2024). SIRT1 Serum Concentrations in Lipodystrophic Syndromes. International Journal of Molecular Sciences, 25(9), 4785. https://doi.org/10.3390/ijms25094785
Vancouver
Salvatori L, Magno S, Ceccarini G, Tozzi R, Contini S, Pelosini C, et al. SIRT1 Serum Concentrations in Lipodystrophic Syndromes. International Journal of Molecular Sciences. 2024;25(9):4785. doi:10.3390/ijms25094785
BibTeX
@article{Salvatori2024,
author = {Salvatori, Luisa and Magno, Silvia and Ceccarini, Giovanni and Tozzi, Rossella and Contini, Savina and Pelosini, Caterina and Santini, Ferruccio and Gnessi, Lucio and Mariani, Stefania},
title = {SIRT1 Serum Concentrations in Lipodystrophic Syndromes},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {9},
pages = {4785},
doi = {10.3390/ijms25094785}
}
EUVIMED